Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic
  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Global Molecular Quality Controls Market to Reach $280.1 Million by 2027

New York, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Molecular Quality Controls Industry" - https://www.reportlinker.com/p06032265/?utm_source=GNW
5 Million in the year 2020, is projected to reach a revised size of US$280.1 Million by 2027, growing at aCAGR of 8.8% over the period 2020-2027. Independent Controls, one of the segments analyzed in the report, is projected to record 8.1% CAGR and reach US$170.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instrument-Specific Controls segment is readjusted to a revised 9.9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $46 Million, While China is Forecast to Grow at 8.2% CAGR
- The Molecular Quality Controls market in the U.S. is estimated at US$46 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$48.8 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

- Select Competitors (Total 33 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Microbiologics, Inc.
  • Qnostics
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • SeraCare Life Sciences, Inc.
  • SERO AS
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix Corporation




Read the full report: https://www.reportlinker.com/p06032265/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Molecular Quality
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 2: World Historic Review for Molecular Quality Controls
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Molecular Quality
Controls by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Independent
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Independent Controls by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Independent Controls by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for
Instrument-Specific Controls by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Instrument-Specific Controls
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Instrument-Specific
Controls by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Single-Analyte
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Single-Analyte Controls by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Single-Analyte Controls
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Multi-Analyte
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Multi-Analyte Controls by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Multi-Analyte Controls
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Oncology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 19: World Current & Future Analysis for Genetic Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Genetic Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Genetic Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Infectious
Diseases by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 23: World Historic Review for Infectious Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Infectious Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Molecular Quality Controls by
Product - Independent Controls and Instrument-Specific Controls
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Molecular Quality Controls by
Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Molecular Quality Controls by
Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 40: Canada Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 44: Canada Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

JAPAN
Table 46: Japan Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 48: Japan 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 49: Japan Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

CHINA
Table 55: China Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 57: China 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 58: China Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 62: China Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

EUROPE
Table 64: Europe Current & Future Analysis for Molecular
Quality Controls by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ for Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Molecular Quality Controls
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Molecular Quality
Controls by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 74: Europe Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

FRANCE
Table 76: France Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 78: France 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 79: France Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 83: France Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

GERMANY
Table 85: Germany Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 87: Germany 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 88: Germany Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 92: Germany Historic Review for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

ITALY
Table 94: Italy Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 96: Italy 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 97: Italy Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 101: Italy Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 103: UK Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 104: UK Historic Review for Molecular Quality Controls by
Product - Independent Controls and Instrument-Specific Controls
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 105: UK 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 106: UK Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Molecular Quality Controls by
Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 110: UK Historic Review for Molecular Quality Controls by
Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 112: Rest of Europe Current & Future Analysis for
Molecular Quality Controls by Product - Independent Controls
and Instrument-Specific Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 113: Rest of Europe Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 114: Rest of Europe 15-Year Perspective for Molecular
Quality Controls by Product - Percentage Breakdown of Value
Sales for Independent Controls and Instrument-Specific Controls
for the Years 2012, 2020 & 2027

Table 115: Rest of Europe Current & Future Analysis for
Molecular Quality Controls by Analyte Type - Single-Analyte
Controls and Multi-Analyte Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 116: Rest of Europe Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 117: Rest of Europe 15-Year Perspective for Molecular
Quality Controls by Analyte Type - Percentage Breakdown of
Value Sales for Single-Analyte Controls and Multi-Analyte
Controls for the Years 2012, 2020 & 2027

Table 118: Rest of Europe Current & Future Analysis for
Molecular Quality Controls by Application - Oncology, Genetic
Testing, Infectious Diseases and Other Applications -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027 and % CAGR

Table 119: Rest of Europe Historic Review for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 120: Rest of Europe 15-Year Perspective for Molecular
Quality Controls by Application - Percentage Breakdown of Value
Sales for Oncology, Genetic Testing, Infectious Diseases and
Other Applications for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 121: Asia-Pacific Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 122: Asia-Pacific Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 123: Asia-Pacific 15-Year Perspective for Molecular
Quality Controls by Product - Percentage Breakdown of Value
Sales for Independent Controls and Instrument-Specific Controls
for the Years 2012, 2020 & 2027

Table 124: Asia-Pacific Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 125: Asia-Pacific Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 126: Asia-Pacific 15-Year Perspective for Molecular
Quality Controls by Analyte Type - Percentage Breakdown of
Value Sales for Single-Analyte Controls and Multi-Analyte
Controls for the Years 2012, 2020 & 2027

Table 127: Asia-Pacific Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 128: Asia-Pacific Historic Review for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 129: Asia-Pacific 15-Year Perspective for Molecular
Quality Controls by Application - Percentage Breakdown of Value
Sales for Oncology, Genetic Testing, Infectious Diseases and
Other Applications for the Years 2012, 2020 & 2027

REST OF WORLD
Table 130: Rest of World Current & Future Analysis for
Molecular Quality Controls by Product - Independent Controls
and Instrument-Specific Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 131: Rest of World Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 132: Rest of World 15-Year Perspective for Molecular
Quality Controls by Product - Percentage Breakdown of Value
Sales for Independent Controls and Instrument-Specific Controls
for the Years 2012, 2020 & 2027

Table 133: Rest of World Current & Future Analysis for
Molecular Quality Controls by Analyte Type - Single-Analyte
Controls and Multi-Analyte Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 134: Rest of World Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 135: Rest of World 15-Year Perspective for Molecular
Quality Controls by Analyte Type - Percentage Breakdown of
Value Sales for Single-Analyte Controls and Multi-Analyte
Controls for the Years 2012, 2020 & 2027

Table 136: Rest of World Current & Future Analysis for

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032265/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________


Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.